Skip to content
  • HOME
  • ABOUT

    CPA is the leading national, bipartisan organization exclusively representing domestic producers and workers across many industries and sectors of the U.S. economy.

    • ABOUT CPA
    • STAFF
    • BOARD
    • CONTACT CPA
    • ABOUT CPA
    • STAFF
    • BOARD
    • CONTACT CPA
    LEARN MORE ➔
  • ISSUES

    CPA ADVOCACY ISSUES

    • AGRICULTURE
    • BUY AMERICAN
    • CHINA
    • CURRENCY
    • DE MINIMIS
    • AGRICULTURE
    • BUY AMERICAN
    • CHINA
    • CURRENCY
    • DE MINIMIS
    • HEALTHCARE
    • MANUFACTURING
    • RENEWABLE ENERGY
    • TAX
    • TECHNOLOGY
    • TRADE & TARIFFS
    • HEALTHCARE
    • MANUFACTURING
    • RENEWABLE ENERGY
    • TAX
    • TECHNOLOGY
    • TRADE & TARIFFS
  • NEWSROOM
    CPA Celebrates Member PAI Pharma’s Acquisition of Nivagen Pharmaceuticals

    CPA Celebrates Member PAI Pharma’s Acquisition of Nivagen Pharmaceuticals

    January 13, 2026

    THE LATEST

    • NEWSLETTER: PROSPER WEEKLY
    • PRESS RELEASES
    • CPA OPINION
    • LETTERS & TESTIMONY
    • NEWSLETTER: PROSPER WEEKLY
    • PRESS RELEASES
    • CPA OPINION
    • LETTERS & TESTIMONY

    CPA Celebrates Member PAI Pharma’s Acquisition of Nivagen Pharmaceuticals

    CPA Warns Congress Against Extending Failed AGOA Program Ahead of House Vote

    Guest Opinion: Why a Market Access Charge Would Have Greater Benefits Than Tariffs

    October Trade Deficit Falls 39%, Lowest In Years, But U.S. Will Still Surpass $1 Trillion Goods Gap In 2025

    MORE FROM THE NEWSROOM ➔
  • RESEARCH
  • CONTRIBUTE

    Help us take the next steps to strengthen America's domestic producers.

    Your generous contribution will enable us to keep fighting for the prosperous growth of an industrial strategy in many sectors such as Healthcare, Agriculture, Manufacturing, Trade, Technology & Tax.

    CONTRIBUTE TODAY ➔

Making The Case For Reshoring Critical Drugs, Where 90% Of Inputs Are In China’s Hands

Buy American, China, commentary, Featured Home Page, HealthcareBy Kenneth RapozaApril 23, 2021Leave a comment

How do we bring back generic drug manufacturing to the United States in order to be less reliant on India, China? A National Academies of Science conference brings in some experts to try and answer that, including the chair of CPA Healthcare Committee.

To Build China’s Biotech, Just Keep Stealing: DoJ Jails Two For Spying

China, commentary, Featured Home Page, HealthcareBy Kenneth RapozaApril 23, 2021Leave a comment

The trend continues. A Chinese couple indicted over biotech trade secret’s lifted from Ohio research hospital.

Apple, Tesla CEOs Listen In As Xi Jinping Blasts U.S. ‘Cold War’

Research Hub Articles, China, Commentary Featured, Featured Home PageBy Kenneth RapozaApril 21, 2021Leave a comment

Striking all the right chords and buzzwords, China leader Xi Jinping says what the world needs now is love sweet love. Who’s buying?

Katherine Tai Takes Swipe at Global Companies; Says Environmental Protection a ‘Top Priority’

Agriculture, China, commentary, Commentary Featured, Featured Home Page, Manufacturing, Renewable Energy, TechnologyBy Kenneth RapozaApril 16, 2021Leave a comment

For Katherine Tai and the Biden administration, environmentalism is going to be the core of trade policy. How does that square with heavy polluters like India and China?

Trade Blockage Another Example Why China Decoupling is Necessary

Research Hub Articles, Buy American, China, Commentary Featured, Featured Home Page, Manufacturing, Supply ChainBy Kenneth RapozaApril 16, 20211 Comment

Recent shortages an example of America’s over-bearing dependence on Chinese supply chains. The time is now to take action to reverses this decades-long headwind to U.S. manufacturing and its labor force.

China Dependent Companies Need to Prepare for Continued Supply Chain Changes

Research Hub Articles, Buy American, China, commentary, Commentary Featured, Featured Home Page, Manufacturing, Supply ChainBy Kenneth RapozaApril 13, 2021Leave a comment

Lawyers from Wiley are telling their clients to prepare for ongoing supply disruptions due to Biden’s China policies.

Where Does Europe Stand On The ‘China Tech War’?

China, Featured Home Page, Manufacturing, Research Hub ArticlesBy Kenneth RapozaApril 9, 2021Leave a comment

A Hudson Institute webinar suggests that the U.S. is in a better position to take on China than Europe.

Senator Rick Scott Wants To ‘Keep China Out’ of U.S. Solar Energy

Buy American, China, commentary, Commentary Featured, Featured Home Page, Manufacturing, Renewable Energy, Research Hub Articles, Supply ChainBy Kenneth RapozaApril 1, 20211 Comment

A new bill in the Senate seeks to prevent China solar imports, especially for publicly funded solar installations.

Biden Gives Glimpse Into Infrastructure Goals With American Jobs Plan

Buy American, China, commentary, Commentary Featured, Featured Home PageBy Kenneth RapozaMarch 31, 2021Leave a comment

Biden releases 10-year $2 trillion infrastructure spending plan. Here’s what’s inside.

It’s Official: State Department Says Uyghurs Face Genocide In China

China, commentary, Commentary Featured, Research Hub ArticlesBy Kenneth RapozaMarch 30, 2021Leave a comment

State Department says, in writing, that China is committing genocide.

←1
23456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354
…5556575859→
  • ABOUT
  • NEWSROOM
  • MEMBERSHIP
  • CONTACT
Facebook-f Youtube Linkedin

© 2025 COALITION FOR A PROSPEROUS AMERICA. ALL RIGHTS RESERVED.

Go to Top

⋆ ⋆ ⋆ MENU

  • HOME
  • ABOUT
    • ABOUT CPA
    • STAFF
    • BOARD
    • ADVOCACY
    • MEMBERSHIP
    • HISTORY
    • OUR MISSION
    • OUR VISION
    • CONTACT US
  • ISSUES
    • AGRICULTURE
    • BUY AMERICAN
    • CHINA
    • CURRENCY
    • DE MINIMIS
    • HEALTHCARE
    • MANUFACTURING
    • RENEWABLE ENERGY
    • TAX
    • TECHNOLOGY
    • TRADE & TARIFFS
  • RESEARCH
  • NEWSROOM
    • THE LATEST
    • NEWSLETTER: PROSPER WEEKLY
    • PRESS RELEASES
    • CPA OPINION
    • LETTERS & TESTIMONY
  • CONTRIBUTE
Prosper Weekly

DON'T MISS IT!

Subscribe to CPA's exclusive weekly Newsletter ➔

 Twitter
 Facebook
 LinkedIn
 Copy

Share on Mastodon